Ptc Therapeutics Stock Forecast

Buy or Hold candidate since Jun 04, 2026 Gain 0.33%

The PTC Therapeutics stock price fell by -0.141% on the last day (Monday, 8th Jun 2026) from $70.97 to $70.87. During the last trading day the stock fluctuated 3.11% from a day low at $69.74 to a day high of $71.91. The price has risen in 6 of the last 10 days and is up by 2.99% over the past 2 weeks. Volume has increased on the last day by 335 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $90.13 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.53% during the next 3 months and, with a 90% probability hold a price between $72.80 and $83.41 at the end of this 3-month period.

PTCT Signals & Forecast

The PTC Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $71.01. On a fall, the stock will find some support from the long-term average at approximately $69.89. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, May 26, 2026, and so far it has risen 4.76%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The stock had a Golden Star Signal on Wednesday, August 13, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for PTC Therapeutics stock

PTC Therapeutics finds support from accumulated volume at $68.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.17 between high and low, or 3.11%. For the last week, the stock has had daily average volatility of 4.17%.

Our recommended stop-loss: $68.10 (-3.91%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (PTCT) For The Upcoming Trading Day Of Tuesday 9th

For the upcoming trading day on Tuesday, 9th we expect PTC Therapeutics to open at $70.84, and during the day (based on 14 day Average True Range), to move between $69.43 and $72.31, which gives a possible trading interval of +/-$2.88 (+/-4.15%) up or down from last closing price. If PTC Therapeutics takes out the full calculated possible swing range there will be an estimated 4.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $68.40 (3.49%) than the resistance at $73.69 (3.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PTC Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for PTC Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.780 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 9, 2026 - $70.84 ( 0.0423%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk